New Way to Protect Insulin-Producing Cells from Body Defenses

Topic: Biology

Rice University researchers have developed a method to protect transplanted cells from immune system attacks. They used a protein called interleukin 10 (IL-10) to create a biochemical halo that helps insulin-producing cells survive in diabetic mice for over 100 days.

Scientists at Rice University have made a breakthrough in the treatment of type 1 diabetes (T1D). They have developed a way to protect transplanted cells from being rejected by the body's immune system. This is a major problem in treating T1D, as the immune system often attacks and destroys the implanted cells.

The researchers used a protein called interleukin 10 (IL-10) to create a biochemical halo around the insulin-producing cells. IL-10 is a type of cytokine that helps control the immune response. The team first tested several cytokines, including IL-10, in lab cultures and animal models to see which one was most effective.

The results showed that IL-10 was the best at helping control immune responses. The researchers then packaged IL-10-producing cells and insulin-producing cells inside protective hydrogel capsules and implanted them in diabetic mice. They found that the IL-10 halo helped reduce fibrotic buildup, a process where the immune system walls off the implant with scar-like tissue.

This is an important breakthrough because it could lead to a cure for T1D and improve outcomes for implantable therapies. The researchers also tested the platform in nonhuman primates, where the implants continued producing IL-10 without signs of harmful effects elsewhere in the body.

Why It Matters

This discovery has the potential to transform the lives of millions living with type 1 diabetes. It could shift the paradigm from daily insulin management to lasting metabolic freedom.

Key Facts

• Rice University researchers have developed a method to protect transplanted cells from immune system attacks using interleukin 10 (IL-10).
• The IL-10 halo helped insulin-producing cells survive in diabetic mice for over 100 days, nearly five times longer than cells implanted without protection.
• The breakthrough could lead to a cure for type 1 diabetes and improve outcomes for implantable therapies.
• The researchers tested the platform in nonhuman primates with promising results.
• The study was published in Science Advances, a peer-reviewed publication.

Key Terms

Interleukin 10 (IL-10)

A type of cytokine that helps control the immune response.

Cytokines

Proteins that interact with immune cells and help keep them in check.

Fibrosis

A process where the immune system walls off an implant with scar-like tissue.

Implications

This discovery has the potential to transform the lives of millions living with type 1 diabetes. It could shift the paradigm from daily insulin management to lasting metabolic freedom.